4//SEC Filing
BRYNJELSEN SEAN 4
Accession 0001493152-23-006671
CIK 0001710340other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:10 PM ET
Size
5.7 KB
Accession
0001493152-23-006671
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option (Right to buy)
2023-03-03+350,381→ 1,951,881 totalExercise: $3.47Exp: 2033-02-19→ Common Stock (350,381 underlying)
Footnotes (2)
- [F1]Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023.
- [F2]The Shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on February 20, 2027.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001669976
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 4:10 PM ET
- Size
- 5.7 KB